{"id":535499,"date":"2026-07-06T09:43:11","date_gmt":"2026-07-06T09:43:11","guid":{"rendered":"https:\/\/www.newsbeep.com\/ie\/535499\/"},"modified":"2026-07-06T09:43:11","modified_gmt":"2026-07-06T09:43:11","slug":"bundibugyo-virus-trial-begins-enrolment","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/ie\/535499\/","title":{"rendered":"Bundibugyo virus trial begins enrolment"},"content":{"rendered":"<p>PATIENT enrolment has begun in a clinical trial investigating potential treatments for\u00a0<a href=\"https:\/\/www.emjreviews.com\/general-healthcare\/news\/who-determines-deadly-ebola-outbreak-a-public-health-emergency\/\" rel=\"nofollow noopener\" target=\"_blank\">Bundibugyo virus disease (BVD),<\/a>\u00a0a form of Ebola disease caused by the\u00a0Bundibugyo virus that can lead to severe illness and death.\u00a0<\/p>\n<p>The\u00a0PARTNERS\u00a0trial is recruiting patients in the Democratic Republic of the Congo\u00a0(DRC)\u00a0to assess whether two antiviral treatments \u2013 the monoclonal antibody MBP134 and remdesivir \u2013 can improve survival in people with confirmed BVD.\u00a0Researchers will also investigate whether combining the two therapies provides\u00a0additional\u00a0benefit.\u00a0<\/p>\n<p>The trial has been\u00a0established\u00a0through an international collaboration sponsored by the World Health Organization (WHO), and coordinated\u00a0by\u00a0research partners in the DRC,\u00a0Belgium\u00a0and the UK, with support from the Africa Centres for Disease Control and Prevention.\u00a0<\/p>\n<p>Since the current outbreak began, more than 1,400 people have been diagnosed with BVD in the DRC.\u00a0\u00a0Although 210 people have recovered, an estimated 440 have died of the disease. Although treatments are available for some forms of Ebola virus disease, there are currently no approved therapies for BVD.\u00a0<\/p>\n<p>Dr Tedros Adhanom Ghebreyesus, Director-General, World Health Organization (WHO), Geneva, Switzerland, said: \u201cEven without approved therapeutics, people are recovering from this disease, but safe and effective treatments could save many more lives.\u00a0<\/p>\n<p>PLATFORM Trial Aims to Strengthen Outbreak Response\u00a0<\/p>\n<p>Ghebreyesus\u00a0added that\u00a0\u201cThe PARTNERS trial, established with national authorities and scientific partners in record time, offers real hope that we can deliver concrete results for \u2013 and with \u2013 the communities at the heart of the outbreak.\u201d\u00a0<\/p>\n<p>Designed as a platform trial, PARTNERS can evaluate\u00a0additional\u00a0treatments as new candidates become available.\u00a0\u00a0<\/p>\n<p>\u201cWe urgently need treatments that can help people affected by Bundibugyo virus disease. One of the key lessons from recent outbreaks is that research needs to happen alongside the response, not after it,\u201d said Professor Amanda Rojek, PARTNERS Trial Operations Lead and Associate Professor of Health Emergencies, at the Pandemic Sciences Institute, University of Oxford.\u00a0<\/p>\n<p>The randomised, controlled trial is open to patients of any age with confirmed BVD. Participants will receive supportive care in line with WHO guidance, including fluids, electrolyte replacement, oxygen therapy, blood pressure\u00a0management\u00a0and pain relief, alongside any investigational treatment. Researchers will\u00a0monitor\u00a0participants for at least 28 days after enrolment, while an independent data and safety monitoring board will regularly review study data.\u00a0<\/p>\n<p>Featured image:\u00a0Sharafmaksumov\u00a0on Adobe Stock\u00a0<\/p>\n<p>\u00a0<\/p>\n","protected":false},"excerpt":{"rendered":"PATIENT enrolment has begun in a clinical trial investigating potential treatments for\u00a0Bundibugyo virus disease (BVD),\u00a0a form of Ebola&hellip;\n","protected":false},"author":2,"featured_media":535500,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[10],"tags":[103,61,60],"class_list":["post-535499","post","type-post","status-publish","format-standard","has-post-thumbnail","category-health","tag-health","tag-ie","tag-ireland"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/posts\/535499","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/comments?post=535499"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/posts\/535499\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/media\/535500"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/media?parent=535499"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/categories?post=535499"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/tags?post=535499"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}